المؤلفون: Pontier-Marchandise S; Department of Respiratory Medicine, Larrey Hospital, Toulouse University Hospital, Toulouse, France. Electronic address: pontier.s@chu-toulouse.fr., Texereau J; Lung Function & Respiratory Physiology Units, Cochin University Hospital, AP-HP, Paris, France; VitalAire, Air Liquide Healthcare, Bagneux, France., Prigent A; Pulmonology Medical Group, Polyclinique Saint-Laurent, Rennes, France., Gonzalez-Bermejo J; Sorbonne Université, INSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, F-75005, Paris, France; AP-HP, Groupe Hospitalier Universitaire APHP-Sorbonne Université, site Pitié-Salpêtrière, SSR respiratoire (Département R3S), F-75013, Paris, France., Rabec C; Pulmonary Department and Respiratory Critical Care Unit, Dijon University Hospital, Dijon, France., Gagnadoux F; Department of Respiratory and Sleep Medicine, Angers University hospital and INSERM 1083, UMR CNRS 6015, MITOVASC, Equipe CarME, SFR ICAT, University of Angers, 49000 Angers, France., Letierce A; QualityStat - Morangis, France., Winck JC; Faculdade de Medicina da Universidade do Porto, Porto, Portugal.

المصدر: Respiratory medicine and research [Respir Med Res] 2023 Nov; Vol. 84, pp. 101028. Date of Electronic Publication: 2023 May 25.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Masson SAS Country of Publication: France NLM ID: 101746324 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2590-0412 (Electronic) Linking ISSN: 25900412 NLM ISO Abbreviation: Respir Med Res Subsets: MEDLINE

مواضيع طبية MeSH: Noninvasive Ventilation*/adverse effects , Respiratory Insufficiency*/therapy , Respiratory Insufficiency*/etiology , Acidosis, Respiratory*/etiology, Humans ; Cohort Studies ; Lung

المؤلفون: Debieuvre D; Respiratory Medicine Department, Groupe Hospitalier de la Région Mulhouse Sud-Alsace, Hôpital Emile Muller, Mulhouse, France., Molinier O; Respiratory Medicine Department, Centre Hospitalier Le Mans, Le Mans, France., Falchero L; Respiratory Medicine Department, L'Hôpital Nord-Ouest, Villefranche-Sur-Saône, France., Locher C; Respiratory Medicine Department, Grand Hôpital de l'Est Francilien (GHEF), Meaux, France., Templement-Grangerat D; Respiratory Medicine Department, Centre Hospitalier Annecy Genevois (CHANGE), Annecy, France., Meyer N; Biostatistician, Public Health Department, CHU de Strasbourg, GMRC, Strasbourg, France., Morel H; Respiratory Medicine Department, Centre Hospitalier Régional D'Orléans Hôpital de La Source, Orléans, France., Duval Y; Respiratory Medicine Department, Hôpital de Cannes Simone Veil, Cannes, France., Asselain B; Methodologist, Groupe Statistique, ARCAGY - GINECO, Paris, France., Letierce A; Biostatistician, QualityStat, Morangis, France., Trédaniel J; Department of Thoracic Oncology, Groupe hospitalier Paris-Saint Joseph, Paris, France., Auliac JB; Respiratory Medicine Department, Centre Hospitalier Intercommunal Créteil, Créteil, France., Bylicki O; Respiratory Medicine Department, Hôpital d'Instruction des Armées Sainte-Anne, Toulon, France., Moreau L; Respiratory Medicine Department, Centre Hospitalier de Colmar, Colmar, France., Fore M; Respiratory Medicine Department, Groupe Hospitalier de la Région Mulhouse Sud-Alsace, Hôpital Emile Muller, Mulhouse, France., Corre R; Respiratory Medicine Department, Centre Hospitalier de Cornouaille, Quimper, France., Couraud S; Respiratory Medicine Department, Centre Hospitalier de Lyon Sud, Hospices Civils de Lyon, Lyon, France., Cortot A; Department of Thoracic Oncology, CHU de Lille, CNRS, Inserm, Institut Pasteur de Lille, UMR9020-U1277-CANTHER, Lille, France.

مؤلفون مشاركون: Study Group KBP-2020-CPHG, KBP-2020-CPHG

المصدر: The Lancet regional health. Europe [Lancet Reg Health Eur] 2022 Aug 29; Vol. 22, pp. 100492. Date of Electronic Publication: 2022 Aug 29 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: [Oxford] Country of Publication: England NLM ID: 101777707 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-7762 (Electronic) Linking ISSN: 26667762 NLM ISO Abbreviation: Lancet Reg Health Eur Subsets: PubMed not MEDLINE

المؤلفون: Gaudet D; ECOGENE-21 and Clinical Lipidology Unit, Community Gene Medicine Center, Department of Medicine, Université de Montréal, Chicoutimi, QC G7H 7K9, Canada., López-Sendón JL; IdiPaz, CIBER-CV, UAM, Hospital Universitario La Paz, Madrid 20846, Spain., Averna M; Department of Health Promotion Sciences, Maternal and Infantile Care, Internal Medicine and Medical Specialties-PROMISE, School of Medicine, University of Palermo, Palermo 90133, Italy., Bigot G; IviData Life Sciences, Levallois-Perret 92300, France., Banach M; Department of Hypertension, Medical University of Lodz, Lodz 90-419, Poland., Letierce A; Sanofi, Chilly-Mazarin 91380, France., Loy M; Sanofi, Bridgewater, NJ 08807, USA., Samuel R; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA., Manvelian G; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA., Batsu I; Sanofi, Bridgewater, NJ 08807, USA., Henry P; Hôpital Lariboisière, Service de Cardiologie, Paris 75010, France.

مؤلفون مشاركون: ODYSSEY APPRISE Study investigators

المصدر: European journal of preventive cardiology [Eur J Prev Cardiol] 2022 Feb 03; Vol. 28 (17), pp. 1864-1872.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101564430 Publication Model: Print Cited Medium: Internet ISSN: 2047-4881 (Electronic) Linking ISSN: 20474873 NLM ISO Abbreviation: Eur J Prev Cardiol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized*/adverse effects, Adult ; Aged ; Canada/epidemiology ; Female ; Humans ; Male ; Middle Aged ; Prospective Studies ; Treatment Outcome

المؤلفون: Ginsberg HN; Columbia University, New York, NY, USA. Electronic address: hng1@cumc.columbia.edu., Rosenson RS; Mount Sinai Icahn School of Medicine, New York, NY, USA., Hovingh GK; Academic Medical Center, Amsterdam, The Netherlands; Novo Nordisk AS, Copenhagen, Denmark., Letierce A; Sanofi, Chilly-Mazarin, France., Samuel R; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Poulouin Y; IT&M Stats, Paris, France., Cannon CP; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.

المصدر: Journal of lipid research [J Lipid Res] 2022 Jan; Vol. 63 (1), pp. 100148. Date of Electronic Publication: 2021 Nov 11.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 0376606 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1539-7262 (Electronic) Linking ISSN: 00222275 NLM ISO Abbreviation: J Lipid Res Subsets: MEDLINE

مواضيع طبية MeSH: Cholesterol, LDL*

المؤلفون: Filleron A; INSERM U 1183, F-75561, Paris.; Service de pédiatrie, Centre hospitalier universitaire de Nîmes, Université Montpellier-Nîmes, F-75561, Paris, France., Tran TA; INSERM U 1183, F-75561, Paris.; Service de pédiatrie, Centre hospitalier universitaire de Nîmes, Université Montpellier-Nîmes, F-75561, Paris, France., Hubert A; Département de Biothérapies (CIC-BTi) et Inflammation-Immunopathologie-Biothérapie (I2B), AP-HP, Hôpital La Pitié-Salpêtrière, F-75561, Paris, France.; Sorbonne Université, INSERM, UMR_S 959, Immunologie-Immunopathologie-Immunothérapie (I3), F-75561, Paris, France., Letierce A; Unité de Recherche Clinique Paris Sud, Hôpital Bicêtre, Paris, France., Churlaud G; Département de Biothérapies (CIC-BTi) et Inflammation-Immunopathologie-Biothérapie (I2B), AP-HP, Hôpital La Pitié-Salpêtrière, F-75561, Paris, France.; Sorbonne Université, INSERM, UMR_S 959, Immunologie-Immunopathologie-Immunothérapie (I3), F-75561, Paris, France., Koné-Paut I; Service de Rhumatologie pédiatrique, Centre Hospitalier Universitaire Bicêtre, Université Paris Sud, Le Kremlin Bicêtre, Paris, France., Saadoun D; Service de Médecine Interne, Centre Hospitalier Universitaire La Pitié Salpêtrière, AP-HP, Paris, France., Cezar R; Laboratoire d'immunologie, Centre Hospitalier Universitaire de Nîmes, Nîmes, France., Corbeau P; Laboratoire d'immunologie, Centre Hospitalier Universitaire de Nîmes, Nîmes, France.; Institut de génétique humaine, CNRS-Université de Montpellier UMR9002, Montpellier., Rosenzwajg M; Département de Biothérapies (CIC-BTi) et Inflammation-Immunopathologie-Biothérapie (I2B), AP-HP, Hôpital La Pitié-Salpêtrière, F-75561, Paris, France.; Sorbonne Université, INSERM, UMR_S 959, Immunologie-Immunopathologie-Immunothérapie (I3), F-75561, Paris, France.

المصدر: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2021 Dec 24; Vol. 61 (1), pp. 422-429.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN: 1462-0332 (Electronic) Linking ISSN: 14620324 NLM ISO Abbreviation: Rheumatology (Oxford) Subsets: MEDLINE

مواضيع طبية MeSH: T-Lymphocytes, Regulatory* , Th17 Cells*, Behcet Syndrome/*immunology, Adolescent ; CD4 Lymphocyte Count ; Case-Control Studies ; Child ; Child, Preschool ; Female ; Humans ; Male

المؤلفون: Alswat K; Department of Medicine, King Saud University, College of Medicine, Liver Disease Research Center, Riyadh, Saudi Arabia. Electronic address: kalswat@ksu.edu.sa., Soliman E; Liver Transplantation and Hepatobiliary-Pancreatic Surgery, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia; Department of Internal Medicine, Minia University, Egypt., Salih I; Liver Transplantation and Hepatobiliary-Pancreatic Surgery, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia., Bashmail A; Department of Medicine, King Saud University, College of Medicine, Liver Disease Research Center, Riyadh, Saudi Arabia., Letierce A; QualityStat, Morangis, France., Benmousa A; Liver Transplantation and Hepatobiliary-Pancreatic Surgery, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia., Alghamdi S; Liver Transplantation and Hepatobiliary-Pancreatic Surgery, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia., Bzeizi KI; Liver Transplantation and Hepatobiliary-Pancreatic Surgery, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia., Alqahtani SA; Liver Transplantation and Hepatobiliary-Pancreatic Surgery, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia; Division of Gastroenterology and Hepatology, Johns Hopkins University, Baltimore, Maryland., Shawkat M; Liver Transplantation and Hepatobiliary-Pancreatic Surgery, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia; Department of Internal Medicine, Minia University, Egypt., Broering DC; Liver Transplantation and Hepatobiliary-Pancreatic Surgery, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia., Al-Hamoudi WK; Department of Medicine, King Saud University, College of Medicine, Liver Disease Research Center, Riyadh, Saudi Arabia; Liver Transplantation and Hepatobiliary-Pancreatic Surgery, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

المصدر: Transplantation proceedings [Transplant Proc] 2021 Sep; Vol. 53 (7), pp. 2339-2345. Date of Electronic Publication: 2021 Aug 31.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Inc Country of Publication: United States NLM ID: 0243532 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2623 (Electronic) Linking ISSN: 00411345 NLM ISO Abbreviation: Transplant Proc Subsets: MEDLINE

مواضيع طبية MeSH: End Stage Liver Disease* , Hepatitis, Autoimmune*/surgery , Liver Transplantation*, Adult ; Child, Preschool ; Female ; Humans ; Living Donors ; Male ; Middle Aged ; Retrospective Studies ; Severity of Illness Index ; Treatment Outcome ; Young Adult

المؤلفون: Vallejo-Vaz AJ; Imperial Centre for Cardiovascular Disease Prevention, Imperial College, UK., Leiter LA; Li Ka Shing Knowledge Institute, University of Toronto, Canada., Del Prato S; Department of Clinical and Experimental Medicine, University of Pisa, Italy., Taskinen MR; Cardiovascular Research Unit, University of Helsinki, Finland., Müller-Wieland D; Department of Internal Medicine I, University Hospital Aachen, German., Bujas-Bobanovic M; Sanofi, Paris, France., Letierce A; Sanofi, Chilly-Mazarin, France., Mandel J; Sanofi, Chilly-Mazarin, France.; IviData Stats, France., Samuel R; Regeneron Pharmaceuticals, Inc., USA., Ray KK; Imperial Centre for Cardiovascular Disease Prevention, Imperial College, UK.

المصدر: European journal of preventive cardiology [Eur J Prev Cardiol] 2020 Oct; Vol. 27 (15), pp. 1663-1674. Date of Electronic Publication: 2020 Feb 23.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101564430 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2047-4881 (Electronic) Linking ISSN: 20474873 NLM ISO Abbreviation: Eur J Prev Cardiol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized/*administration & dosage , Cardiovascular Diseases/*prevention & control , Cholesterol, LDL/*blood , Triglycerides/*blood, Biomarkers/blood ; Cardiovascular Diseases/blood ; Cholesterol, LDL/drug effects ; Dose-Response Relationship, Drug ; Female ; Goals ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage ; Male ; Middle Aged ; Treatment Outcome

المؤلفون: Langslet G; Lipid Clinic, Oslo University Hospital, Aker Sykehus, Bygg 6, Trondheimsveien 235, Postboks 4959 Nydalen, 0424, Oslo, Norway. glangsle@ous-hf.no., Hovingh GK; Academic Medical Center, Amsterdam, The Netherlands.; Novo Nordisk AS, Copenhagen, Denmark., Guyton JR; Duke University Medical Center, Durham, NC, USA., Baccara-Dinet MT; Clinical Development, R&D, Sanofi, Montpellier, France., Letierce A; Biostatistics and Programming, Sanofi, Chilly-Mazarin, France., Manvelian G; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Farnier M; Lipid Clinic, Point Médical and Department of Cardiology, CHU Dijon-Bourgogne, Dijon, France.

المصدر: Cardiovascular drugs and therapy [Cardiovasc Drugs Ther] 2020 Aug; Vol. 34 (4), pp. 515-523.

نوع المنشور: Clinical Trial; Comparative Study; Journal Article; Multicenter Study

بيانات الدورية: Publisher: Kluwer Academic For The International Society For Cardiovascular Pharmacotherapy Country of Publication: United States NLM ID: 8712220 Publication Model: Print Cited Medium: Internet ISSN: 1573-7241 (Electronic) Linking ISSN: 09203206 NLM ISO Abbreviation: Cardiovasc Drugs Ther Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized/*administration & dosage , Anticholesteremic Agents/*administration & dosage , Healthcare Disparities/*trends , Hyperlipoproteinemia Type II/*drug therapy , Practice Patterns, Physicians'/*trends , Serine Proteinase Inhibitors/*administration & dosage, Adult ; Aged ; Antibodies, Monoclonal, Humanized/adverse effects ; Anticholesteremic Agents/adverse effects ; Biomarkers/blood ; Cholesterol, LDL/blood ; Drug Dosage Calculations ; Drug Utilization/trends ; Female ; Genetic Predisposition to Disease ; Heterozygote ; Humans ; Hyperlipoproteinemia Type II/blood ; Hyperlipoproteinemia Type II/diagnosis ; Hyperlipoproteinemia Type II/genetics ; Male ; Middle Aged ; PCSK9 Inhibitors ; Phenotype ; Serine Proteinase Inhibitors/adverse effects

المؤلفون: Bielory L; Hackensack Meridian School of Medicine at Seton Hall University, Departments of Medicine and Ophthalmology, Nutley, New Jersey. Electronic address: drlbielory@gmail.com., Gross GN; Dallas Allergy and Asthma Center, Dallas, Texas., Letierce A; Biostatistics Sanofi R&D, Chilly-Mazarin, France., Melas-Melt L; Biostatistics, Ividata, Levallois-Perret, France., Lucio L; Consumer Healthcare, Medical Department, Sanofi, São Paulo, Brazil.

المصدر: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology [Ann Allergy Asthma Immunol] 2020 Jun; Vol. 124 (6), pp. 616-621.e3. Date of Electronic Publication: 2020 Jan 28.

نوع المنشور: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American College of Allergy, Asthma, and Immunology Country of Publication: United States NLM ID: 9503580 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4436 (Electronic) Linking ISSN: 10811206 NLM ISO Abbreviation: Ann Allergy Asthma Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Anti-Allergic Agents/*administration & dosage , Fluticasone/*administration & dosage , Immunosuppressive Agents/*administration & dosage , Rhinitis, Allergic, Seasonal/*diagnosis , Rhinitis, Allergic, Seasonal/*drug therapy , Triamcinolone Acetonide/*administration & dosage, Administration, Intranasal ; Female ; Humans ; Male ; Randomized Controlled Trials as Topic ; Symptom Assessment ; Treatment Outcome

المؤلفون: Colhoun HM; The Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU, UK. helen.colhoun@igmm.ed.ac.uk., Leiter LA; Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada., Müller-Wieland D; Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany., Cariou B; l'institut du thorax, CHU Nantes, INSERM, CNRS, UNIV Nantes, Nantes, France., Ray KK; Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, Imperial College, London, UK., Tinahones FJ; Department of Clinical Endocrinology and Nutrition (IBIMA), Hospital Virgen de la Victoria, University of Málaga, CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Málaga, Spain., Domenger C; Sanofi, Gentilly, France., Letierce A; Biostatistics and Programming Department, Sanofi, Chilly-Mazarin, France., Israel M; Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USA., Samuel R; Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USA., Del Prato S; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

المصدر: Cardiovascular diabetology [Cardiovasc Diabetol] 2020 Feb 08; Vol. 19 (1), pp. 14. Date of Electronic Publication: 2020 Feb 08.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840 (Electronic) Linking ISSN: 14752840 NLM ISO Abbreviation: Cardiovasc Diabetol Subsets: MEDLINE

مواضيع طبية MeSH: PCSK9 Inhibitors*, Antibodies, Monoclonal, Humanized/*therapeutic use , Anticholesteremic Agents/*therapeutic use , Cholesterol, HDL/*blood , Diabetes Mellitus, Type 2/*drug therapy , Dyslipidemias/*drug therapy , Protease Inhibitors/*therapeutic use , Triglycerides/*blood, Aged ; Antibodies, Monoclonal, Humanized/adverse effects ; Anticholesteremic Agents/adverse effects ; Biomarkers/blood ; Diabetes Mellitus, Type 2/blood ; Diabetes Mellitus, Type 2/diagnosis ; Dyslipidemias/blood ; Dyslipidemias/diagnosis ; Female ; Humans ; Male ; Middle Aged ; Protease Inhibitors/adverse effects ; Time Factors ; Treatment Outcome